Washington - Results from two multicenter, randomized, double-blind trials demonstrate that tacrolimus ointment 0.03 percent (Protopic) is a safe and effective treatment for mild to moderate atopic dermatitis in pediatric patients and adults.
Skin Swab Analysis Reveals Early Predictors of Atopic Dermatitis in Infants
The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis
Lisa Swanson, MD, FAAD: Clinical Pearls and Updates for Pediatric Dermatology
The Cutaneous Connection: Episode 28- The Path to Understanding Pediatric Melanoma
Lawrence Eichenfield, MD: Outlining Late-Breaking INTEGUMENT-PED Data for Roflumilast in Pediatric Patients
Evolution and Innovation in Treating Psoriasis in Pediatric Patients